期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

维持性血液透析患者H型高血压与细胞因子及颈动脉病变的关系 被引量：3

原文传递
导出
摘要 维持性血液透析（MHD）患者普遍存在心血管疾病（CVD），而以动脉粥样硬化（AS）为主要原因的CVD是导致MHD患者死亡的主要原因。H型高血压是指伴有高同型半胱氨酸血症的高血压。研究发现同型半胱氨酸（homocysteine，Hcy）与As的发生密切相关。我们对本院MHD患者H型高血压的发生及与细胞因子和颈动脉病变的关系进行了分析探讨。
作者 邬碧波 张黎明 梅长林 芦怡舟 唐琦
机构地区 上海市闸北区中心医院长征医院闸北分院肾内科 第二军医大学长征医院肾内科解放军肾脏病研究所
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第9期704-705,共2页 Chinese Journal of Nephrology
基金 上海市科委医学引导类重大项目（1141196b0300）
关键词 维持性血液透析患者 颈动脉病变 细胞因子 高血压 H型 高同型半胱氨酸血症 动脉粥样硬化 心血管疾病
分类号 R459.5 [医药卫生—治疗学]
  • 相关文献

参考文献5

  • 1Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis, 2004, 44: 198-206.
  • 2Homocysteine Studies Collaboration. Homocysteine and risk of isehemic heart disease and stroke: a meta- analysis. JAMA, 2002, 288: 2015-2022.
  • 3余月明,侯凡凡,张训,刘俊,胡敏燕,杨凌,许顶立.慢性肾功能衰竭患者的高同型半胱氨酸血症[J].中华肾脏病杂志,2002,18(1):34-37. 被引量：45
  • 4Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA, 2007, 298:1163-1170.
  • 5Van Wagoner DR. Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction? Europace, 2008, 10: 899-900.

二级参考文献13

  • 1Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem, 1994, 40:873-881.
  • 2Jacobsen DW. Cardiovascular disorders (risk assessment) . Clin Chem, 1993, 65: 367R-373R.
  • 3Yeun JY. The role of homocysteine in end - stage renal disease.Seminars in Dialysis, 1998, 11: 95-101.
  • 4Nygard O, Norderhaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 1997, 337: 230-236.
  • 5Bostom AG, Lathrop L. Hyperhomocysteinemia in end- stage renal disease: prevalence, etiology, and potential relationship to artherosclerotic outcomes. Kidney Int, 1997, 52: 10-20.
  • 6Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998,32 Suppl 3: 112-119.
  • 7Yu HH, Joubran R, Asmi M, et al. Agreement among four homocysteine assays and results in patients with coronaryatherosclerosis and controls. Clin Chem, 2000, 46: 258-264.
  • 8Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron, 1995, 70: 62-67.
  • 9Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephron, 1999, 10: 891-900.
  • 10Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation, 1998, 97: 138-141.

共引文献44

同被引文献31

  • 1裴晶晶,郭帅,张春玲,谢克勤,张翠丽,赵秀兰.茶多酚对同型半胱氨酸诱导损伤的人血管内皮细胞纤溶功能的影响[J].卫生研究,2009,38(1):47-50. 被引量：2
  • 2赵璐杰,李超林.终末期肾脏病患者甲状腺功能的变化[J].中国血液净化,2012,11(8):436-438. 被引量：14
  • 3Doneen AL, Bale BF. Carotid intima- media thickness testing as an asymptomatic cardiovascular disease identifier and method for making therapeutie decisions[J]. Postgrad Med, 2013, 125(2): 1088-123.
  • 4Krysiak R, K~dzia A, Krupej- K~dzierska J, et al. Endocrine abnormalities in patients with chronic renal failure - part I[J]. Pol Merkur Lekarski, 2015, 38(227): 288-292.
  • 5Tatar E, Kircelli F, Asci G, et al. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2011, 6(9): 2240-2246.
  • 6Katakami N, Kaneto H, Shimomura I. Carotid ultrasonography: a potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients[J]. J Diabetes Investig, 2014, 5(1): 3-13.
  • 7Rhee CM, Brent GA, Kovesdy CP, et al. Thyroid functional disease: an under- recognized cardiovascular risk factor in kidney disease patients[J]. Nephrol Dial Transplant, 2015, 30(5): 724-737.
  • 8Dousdampanis P, Trigka K, Vagenakis GA, et al. The thyroid and the kidney: a complex interplay in health and disease[J]. Int J Artif Organs, 2014, 37(1): 1-12.
  • 9Hor6~ek J, Dusilov6 Sulkov~t S, Kubi~ov~t M, et al. Thyroid hormone abnormalities in hemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality[J]. Physiol Res, 2012, 61 (5): 495-501.
  • 10Yilmaz MI, Sonmez A, Karaman M, et al. Low triiodothyronine alters flow- mediated vasodilatation in advanced nondiabetic kidney disease[J]. Am J Nephroi, 2011, 33(1): 25-32.

引证文献3

二级引证文献33

中华肾脏病杂志
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部